Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Shree Sharma

Concepts (117)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Renal Cell
2
2010
105
0.670
Why?
Kidney Neoplasms
2
2010
177
0.640
Why?
Glomerulonephritis, Membranous
3
2020
27
0.540
Why?
Diabetic Nephropathies
1
2013
61
0.430
Why?
Kidney
2
2013
665
0.390
Why?
Angiogenesis Inducing Agents
1
2010
8
0.380
Why?
Glomerulonephritis, IGA
1
2010
5
0.370
Why?
PAX2 Transcription Factor
1
2010
22
0.370
Why?
Podocytes
1
2010
19
0.370
Why?
Carcinoma, Papillary
1
2010
48
0.360
Why?
Neovascularization, Physiologic
1
2010
68
0.360
Why?
Proto-Oncogene Proteins B-raf
1
2010
79
0.350
Why?
Diabetes Mellitus
1
2013
285
0.340
Why?
Vascular Endothelial Growth Factor A
1
2010
201
0.330
Why?
Neovascularization, Pathologic
1
2010
161
0.320
Why?
Angiogenesis Inhibitors
1
2010
187
0.310
Why?
Heart Diseases
1
2010
206
0.310
Why?
Immunohistochemistry
1
2010
973
0.300
Why?
Colorectal Neoplasms
1
2010
236
0.290
Why?
Adenocarcinoma
1
2010
396
0.270
Why?
Kidney Diseases
2
2019
214
0.240
Why?
Lupus Nephritis
1
2020
17
0.180
Why?
Lupus Erythematosus, Systemic
1
2020
70
0.180
Why?
Biopsy
2
2013
584
0.180
Why?
Glomerulonephritis
1
2019
13
0.170
Why?
Humans
13
2020
49974
0.140
Why?
Proflavine
1
2015
1
0.130
Why?
Endothelin-1
1
2015
31
0.120
Why?
Fluorescent Dyes
1
2015
102
0.120
Why?
Point-of-Care Systems
1
2015
56
0.120
Why?
Phenazopyridine
1
2014
3
0.120
Why?
Nephritis, Interstitial
1
2014
9
0.120
Why?
Contrast Media
1
2015
184
0.110
Why?
Glomerular Filtration Rate
1
2013
111
0.110
Why?
Myocardium
1
2015
436
0.100
Why?
Vascular Endothelial Growth Factors
1
2010
15
0.090
Why?
Microscopy, Electron, Transmission
1
2010
75
0.090
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2010
11
0.090
Why?
Proteinuria
1
2010
39
0.090
Why?
Hematuria
1
2010
26
0.090
Why?
Fluorescent Antibody Technique
1
2010
108
0.090
Why?
Colonic Neoplasms
1
2012
161
0.090
Why?
Fibroblast Growth Factors
1
2010
47
0.090
Why?
Neoplasms
1
2020
1235
0.090
Why?
Patents as Topic
1
2010
8
0.090
Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2010
8
0.090
Why?
Female
5
2019
26472
0.090
Why?
DNA Mutational Analysis
1
2010
175
0.090
Why?
Integrins
1
2010
31
0.090
Why?
Neoplasm Metastasis
1
2010
231
0.090
Why?
DNA, Neoplasm
1
2010
147
0.090
Why?
Cell Nucleus
1
2010
183
0.090
Why?
Gene Expression Regulation
1
2015
976
0.090
Why?
Matrix Metalloproteinases
1
2010
48
0.090
Why?
Genetic Therapy
1
2010
114
0.090
Why?
Amlodipine
1
2009
14
0.090
Why?
Renal Insufficiency
1
2010
109
0.090
Why?
Aging
1
2015
687
0.090
Why?
Fluorobenzenes
1
2009
21
0.090
Why?
Cardiomegaly
1
2009
34
0.090
Why?
TOR Serine-Threonine Kinases
1
2010
77
0.090
Why?
Immunoglobulin G
2
2020
186
0.090
Why?
Hypercholesterolemia
1
2009
36
0.090
Why?
Stem Cell Transplantation
1
2010
181
0.080
Why?
Calcium Channel Blockers
1
2009
62
0.080
Why?
Intracellular Signaling Peptides and Proteins
1
2010
142
0.080
Why?
Male
6
2020
25241
0.080
Why?
Sulfonamides
1
2009
129
0.080
Why?
Sensitivity and Specificity
1
2010
861
0.080
Why?
Pyrimidines
1
2009
192
0.080
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2009
138
0.080
Why?
Nanoparticles
1
2010
145
0.080
Why?
Drug Delivery Systems
1
2010
138
0.080
Why?
Predictive Value of Tests
1
2010
903
0.080
Why?
Aged
3
2020
9310
0.070
Why?
Diagnosis, Differential
1
2010
1037
0.070
Why?
Models, Biological
1
2010
727
0.070
Why?
Antibodies, Monoclonal
1
2010
459
0.070
Why?
Retrospective Studies
1
2013
6108
0.050
Why?
Middle Aged
2
2013
12069
0.050
Why?
Neural Cell Adhesion Molecules
1
2020
9
0.050
Why?
Thrombospondins
1
2020
8
0.050
Why?
Receptors, Phospholipase A2
1
2020
14
0.050
Why?
Calcium-Binding Proteins
1
2020
54
0.050
Why?
Autoantigens
1
2020
58
0.050
Why?
Autoantibodies
1
2020
116
0.040
Why?
Kidney Glomerulus
1
2019
39
0.040
Why?
Multiple Myeloma
1
2012
2929
0.040
Why?
Aspartic Acid Endopeptidases
1
2015
16
0.030
Why?
beta-Galactosidase
1
2015
33
0.030
Why?
Gene Knockdown Techniques
1
2015
106
0.030
Why?
Metalloendopeptidases
1
2015
70
0.030
Why?
Microscopy, Fluorescence
1
2015
162
0.030
Why?
Estrogen Receptor alpha
1
2015
89
0.030
Why?
RNA Interference
1
2015
179
0.030
Why?
Enzyme Activation
1
2015
276
0.030
Why?
Fibrosis
1
2015
179
0.030
Why?
Up-Regulation
1
2015
452
0.030
Why?
Fibroblasts
1
2015
345
0.030
Why?
Mice
2
2015
5739
0.030
Why?
Fatal Outcome
1
2012
195
0.020
Why?
Cell Line, Tumor
1
2015
1403
0.020
Why?
Cholesterol, Dietary
1
2009
19
0.020
Why?
Receptors, LDL
1
2009
66
0.020
Why?
Lipids
1
2009
147
0.020
Why?
Drug Therapy, Combination
1
2009
377
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
595
0.020
Why?
Signal Transduction
1
2015
1618
0.020
Why?
Body Weight
1
2009
513
0.020
Why?
Animals
2
2015
13187
0.020
Why?
Hematopoietic Stem Cell Transplantation
1
2012
565
0.020
Why?
Gene Expression
1
2009
609
0.020
Why?
Blood Pressure
1
2009
512
0.020
Why?
Mice, Knockout
1
2009
841
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2012
989
0.020
Why?
Disease Models, Animal
1
2009
1455
0.010
Why?
Treatment Outcome
1
2009
5141
0.010
Why?
Sharma's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description